
Gauging physician awareness of nucleic acid-based therapies.

Gauging physician awareness of nucleic acid-based therapies.

Despite the buzz, physicians have limited familiarity and understanding with the burgeoning category of nucleic acid-based therapies, writes Meghan Oates-Zalesky.

Data shows cultural gaps and highlights a C-level fix.

Published: November 6th 2018 | Updated: November 15th 2020

Published: November 4th 2019 | Updated: November 15th 2020

Published: December 1st 2019 | Updated: November 15th 2020